Tuesday, May 16, 2017 8:59:02 AM
If you have read back a bit on our postings, you may have picked up on this already, but if not you will note that the big issues most discussed on the board tend to be the following:
Is the new management team going to bring this program to a successful conclusion?
How will funding be handled moving forward?
Would a reverse split and possible uplisting be beneficial?
Are new members of the Surgeon Advisory Board (prominent/respected surgeons in their respective specialties) good indicators of Titan's future?
Will Titan partner up or be bought by another major player (Verb being the most discussed possibility)?
Not sure about your background or your involvement with Titan as a shareholder or otherwise interested party, but we would certainly welcome any input you have to offer!
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM